Lima Memorial Health System Logo
Approximate ER WAIT TIME WAIT TIME MACRO

Health Library

Metastatic pleural tumor
Site Map

Metastatic pleural tumor

Tumor - metastatic pleural

Metastatic pleural tumor is a type of cancer that has spread from another organ to the thin membrane (pleura) surrounding the lungs and lining the inside of the chest cavity.

Images

Pleural space

I Would Like to Learn About:

Causes

The blood and lymph systems can carry cancer cells to other organs in the body. There, they can produce new growths or tumors.

Almost any type of cancer can spread to the lungs and involve the pleura.

Symptoms

Symptoms may include any of the following:

Exams and Tests

Your health care provider will examine you and ask about your medical history and symptoms. Tests that may be done include:

Treatment

Pleural tumors usually can't be removed with surgery. The original (primary) cancer should be treated. Chemotherapy may be used, depending on the type of primary cancer.

Your provider may recommend thoracentesis if you have a lot of fluid collecting around your lungs and you have shortness of breath or low blood oxygen levels. After the fluid is removed, your lungs will be able to expand more. This allows you to breathe easier.

To prevent the fluid from collecting again, medicine may be placed directly into your chest space through a tube, called a catheter. Or, your surgeon may spray a medicine or talc on the lung surface during the procedure. This procedure is called pleurodesis and may help seal the space around your lungs to prevent the fluid from returning.

Support Groups

You can ease the stress of illness by joining a support group where members share common experiences and problems.

Outlook (Prognosis)

The survival time varies greatly from one month to, infrequently, several years. The outlook depends on:

  • The location of pleural tumors
  • The cell type of pleural tumors
  • The person's age and general health
  • Whether surgery is an option
  • The person's response to treatment

You and your family may want to start thinking about end-of-life planning, such as:

The 1-year survival rate (number of people who live for more than 1 year after diagnosis) is around 25% for people with pleural tumors that have spread from other parts of the body.

Possible Complications

Health problems that may result include:

  • Side effects of chemotherapy or radiation therapy
  • Continued spread of the cancer

Prevention

Early detection and treatment of primary cancers may prevent metastatic pleural tumors in some people.

Related Information

Cancer
Pleural effusion
Incidence

References

Arenberg DA, Reddy RM. Metastatic malignant tumors. In: Broaddus VC, Ernst JD, King TE, et al, eds. Murray and Nadel's Textbook of Respiratory Medicine. 7th ed. Philadelphia, PA: Elsevier; 2022:chap 79.

Davies HE, Sterman D, Lee YCG. Pleural malignancy. In: Broaddus VC, Ernst JD, King TE, et al, eds. Murray and Nadel's Textbook of Respiratory Medicine. 7th ed. Philadelphia, PA: Elsevier; 2022:chap 114.

Kaider-Person O, Zagar T, Haithcock BE, Weiss J. Diseases of the pleura and mediastinum. In: Niederhuber JE, Armitage JO, Kastan MB, Doroshow JH, Tepper JE, eds. Abeloff's Clinical Oncology. 6th ed. Philadelphia, PA: Elsevier; 2020:chap 70.

McCool FD. Diseases of the diaphragm, chest wall, pleura, and mediastinum. In: Goldman L, Cooney KA, eds. Goldman-Cecil Medicine. 27th ed. Philadelphia, PA: Elsevier; 2024:chap 86.

National Cancer Institute website. Metastatic cancer: When cancer spreads. www.cancer.gov/types/metastatic-cancer. Updated January 17, 2025. Accessed May 31, 2026.

Rossetti NE, Tohmasi S, Onaitis MW, Kozower BD. Lung, chest wall, pleura, and mediastinum. In: Tyler DS, Hayes-Dixon A, Hines OJ, et al, eds. Sabiston Textbook of Surgery: The Biological Basis of Modern Surgical Practice. 22nd ed. Philadelphia, PA: Elsevier; 2026:chap 110.

BACK TO TOP

Review Date: 5/1/2026  

Reviewed By: Warren Brenner, MD, Oncologist, Lynn Cancer Institute, Boca Raton, FL. Review provided by VeriMed Healthcare Network. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.

ADAM Quality Logo

A.D.A.M., Inc. is accredited by URAC, for Health Content Provider (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics. This site complies with the HONcode standard for trustworthy health information: verify here.

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. No warranty of any kind, either expressed or implied, is made as to the accuracy, reliability, timeliness, or correctness of any translations made by a third-party service of the information provided herein into any other language.

© 1997- 2026 A.D.A.M., a business unit of Ebix, Inc. Any duplication or distribution of the information contained herein is strictly prohibited.

All content on this site including text, images, graphics, audio, video, data, metadata, and compilations is protected by copyright and other intellectual property laws. You may view the content for personal, noncommercial use. Any other use requires prior written consent from Ebix. You may not copy, reproduce, distribute, transmit, display, publish, reverse-engineer, adapt, modify, store beyond ordinary browser caching, index, mine, scrape, or create derivative works from this content. You may not use automated tools to access or extract content, including to create embeddings, vectors, datasets, or indexes for retrieval systems. Use of any content for training, fine-tuning, calibrating, testing, evaluating, or improving AI systems of any kind is prohibited without express written consent. This includes large language models, machine learning models, neural networks, generative systems, retrieval-augmented systems, and any software that ingests content to produce outputs. Any unauthorized use of the content including AI-related use is a violation of our rights and may result in legal action, damages, and statutory penalties to the fullest extent permitted by law. Ebix reserves the right to enforce its rights through legal, technological, and contractual measures.

adam.com

A.D.A.M. content is best viewed in IE9 or above, Firefox and Google Chrome browser.